Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Uni-Bio Science Acquires Rights to Jiangsu Hansoh's Diabetes Drug (in: Deals & Financings)
  Lee's Pharma to Market Solasia's Anti-Nausea Patch in China (in: Deals & Financings)
  Shenzhen Hepalink Invests $13 Million in Canada's OncoQuest (in: Deals & Financings)
  ZAI Lab Acquires China Rights to Hanmi Lung Cancer Drug (in: Deals & Financings)
  Week in Review: CFDA Begins Reform of China Drug Approval Process (in: Week in Review)
  China's Spending for Drugs to Rise 6-9% during 2016-2020: IMS (in: Industry Insights)
  Nantong Jinghua In-licenses Two Cancer mAbs for $50 Million (in: Deals & Financings)
  CFDA Issues New Drug/Clinical Trial Approval Regulations (in: Gov't & Regulatory)
  Tianjin Tasly Starts $784 Million China Healthcare Fund (in: Deals & Financings)
  Fresenius Opens Shanghai R&D Center for Renal Products (in: News & Analysis)


ChinaBio® Events
Suzhou, China
May 18 - 19, 2016

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors